Binedaline
Chemical compound
- None
- In general: unscheduled
- N,N,N-Trimethyl-N-(3-phenylindol-1-yl)ethane-1,2-diamine
- 60662-16-0
N
- 42510
- 38769
Y
- 3AVG9P140R
- ChEMBL2104611 N
- DTXSID20209472
- Interactive image
- c1cccc2c1c(cn2N(CCN(C)C)C)c3ccccc3
InChI
- InChI=1S/C19H23N3/c1-20(2)13-14-21(3)22-15-18(16-9-5-4-6-10-16)17-11-7-8-12-19(17)22/h4-12,15H,13-14H2,1-3H3Y
- Key:SXYFFMXPDDGOEK-UHFFFAOYSA-NY
N
Y (what is this?) (verify)Binedaline (also called binodaline or binedaline hydrochloride;[1]) is a drug that was investigated as an antidepressant in the 1980s but was never marketed.[2][3] It acts as a selective norepinephrine reuptake inhibitor (Ki = 25 nM), with relatively insignificant influence on the serotonin (Ki = 847 nM) and dopamine (Ki >= 2 μM) transporters.[4] It has negligible affinity for the α-adrenergic, mACh, H1, or 5-HT2 receptors.[4]
Synthesis
Grignard reaction of 2-aminobenzophenone [2835-77-0] (1) with methylmagnesium bromide and dehydration of the tertiary carbinol gives 2-(1-phenylvinyl)aniline [64097-92-3] (2). In an example of the Widman‐Stoermer Synthesis, treatment with nitrous acid followed by basification of the diazonium species with ammonia causes an intramolecular cyclization to afford 4-phenylcinnoline [21874-06-6] (3). Hydrogenation would give 4-Phenyl-1,4-dihydrocinnoline, CID:14175750 (4). The presence of acetic acid gives (5). The reaction with Methyl p-toluenesulfonate [80-48-8] leads to CID:20337750 (6). Acid hydrolysis gives N-methyl-3-phenylindol-1-amine [57647-15-1] (7). Sodamide is then used to abstract the amine proton; alkylation of then anionic species with 2-dimethylaminoethylchloride [107-99-3] (8) then concludes the synthesis of binedaline (9).
See also
Widman‐Stoermer Synthesis also used for the synthesis of Cintazone [2056-56-6].
References
- ^ Milne GW (2017). "3043: Binedaline hydrochloride". In Milne GW (ed.). Drugs: Synonyms and Properties. Routledge. ISBN 9781351755092.
- ^ Faltus F, Geerling FC (1984). "A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression". Neuropsychobiology. 12 (1): 34–38. doi:10.1159/000118107. PMID 6239991.
- ^ Triggle DJ (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
- ^ a b Morin D, Zini R, Urien S, Tillement JP (April 1989). "Pharmacological profile of binedaline, a new antidepressant drug". The Journal of Pharmacology and Experimental Therapeutics. 249 (1): 288–296. PMID 2540319.
- ^ Schatz F, Jahn U, Wagner-Jauregg T, Zirngibl L, Thiele K (1980). "1-amino-3-phenylindoles with antidepressant activity. Binodaline hydrochloride and related substances". Arzneimittel-Forschung. 30 (6): 919–923. doi:10.1002/chin.198038207. PMID 7191264.
- ^ DE 2512702, Fischer K, Jahn U, Schatz F, Stammbach C, Thiele K, Wagner-Jauregg T. Zirngibl L, "New Hydrazines and Methods of Manufacturing Them", issued 23 September 1982, assigned to Siegfried AG
- ^ US 4204998, Schatz F, Stammbach C, Thiele K, Theodor W. Wagner-Jauregg, Zirngibl L, Fischer J, Jahn U, "N-Amino indole derivatives having pharmacological activity", issued 27 May 1980, assigned to Siegfried AG
- v
- t
- e
Specific reuptake inhibitors and/or receptor modulators | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||
| |||||||
| |||||||
Miscellaneous | |
|---|---|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This article about an amine is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
